We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Industry Bashes FDA’s Social Media Guidance
Drugmakers want the FDA to soften language in its first guidance on social media marketing that would make companies responsible for third-party content.